JCEM letter questions tirzepatide findings in partial lipodystrophy

The wire

1. 01The Journal of Clinical Endocrinology and Metabolism published a letter to the editor from Akinci and Oral on evaluating tirzepatide's therapeutic impact in people with partial lipodystrophy.
2. 02Lipodystrophy specialists are among the few clinicians using incretins off-label in this population, so published correspondence shapes practice discussion.
3. 03Correspondence only, with no new patient data; the underlying study's conclusions and any author reply remain the substance to watch.

From the source

Letter to the editor from Akinci and Oral: "Evaluating the therapeutic impact of tirzepatide in people with partial lipodystrophy"

The Journal of clinical endocrinology and metabolism · 2026 Sep 22 · Akinci B, Oral EA et al.